Dr Raphael Twerenbold
Cardiologist, University Hospital Basel, Switzerland

Switching from Conventional to hs-Troponin


  • Alignment of key stakeholders (ED physicians, Cardiologists, Lab experts) to support the concept of switching
  • Stakeholders can choose to familiarize with the 0h / 3h algorithm before initiating the 0h / 1h algorithm
  • The use of higher-sensitivity assay improves the safety for patients

Transcript of above video:

If an institution thinks about switching from a conventional to a high sensitive cardiac troponin assay, I think it’s crucial to consider that you have to get together all key opinion leaders within institution. So in the case of cardiac troponin, the cardiologists, the ED Physiancs, but also the lab experts. Because they need to support the concept, and the concept does not only consist of switching to the new assay, but also to combine it with institution-specific algorithm.

So, a helpful approach might be that you first choose to go to the higher sensitivity cardiac troponin assay, using the 0 hr / 3 hr algorithm, so that you can get familiar with this new assay and get confidence in it. And then later go on to the 1-hour algorithm, because the introduction of high sensitivity cardiac troponin assays improves the safety for the patients, which is more important.

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy. [...]


CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi